Gene and Cell Therapies-Market Access and Funding
Contents:
Chapter 1 Introduction to cell and gene therapies concepts and definitions in US and EU
Chapter 2 cell and gene therapies: genuine products and potential for dramatic value
Chapter 3 cell and gene therapies: Regulatory aspects in US and EU
Chapter 4 the need for new HTA reference case for cell and gene therapies
Chapter 5 How to mitigate cell and gene therapies uncertainties and HTA risk adverse attitude?
Chapter 6 Cell and gene therapies funding: challenges and solutions for patients’ access
Chapter 7 Conclusion
